2026 International Spring Forum
April 15, 2026 | 12:00 PM EST
S10 E1: Connecting Oncology Care Across Borders
Published Date: February 19, 2026
Share
With podcast host, Ginger Blackmon, and featuring Eoin Tabb, Chief II Pharmacist, Clinical Cancer Services.
Season 10, Episode 1 of the PQI Podcast kicks off with a global perspective on cancer care, featuring Eoin Tabb, a leading oncology and haematology pharmacist in Ireland. Eoin serves as Chief 2 Pharmacist for Clinical Cancer Services at University Hospital Waterford, hosts the Irish Haematology Oncology Podcast, and is the Chairperson of the Irish Pharmacy Haematology Oncology Society.
In this episode:
- How oncology and haematology pharmacy practice is structured in Ireland
- The role of pharmacists within multidisciplinary cancer care teams
- How digital health and artificial intelligence are being applied in real-world oncology settings
- Opportunities for shared learning and collaboration across oncology systems
This episode also introduces the 2026 NCODA Global Oncology & Haematology Congress in Dublin, Ireland, March 11–12, 2026. This international gathering is designed to foster collaboration and shared best practices in cancer care. Learn more.
Recent Episodes
S9 Bonus Episode: From Patient to MIP Advocate
Bill Wimbiscus, a longtime journalist and NCODA collaborator, shares his multiple myeloma story and the real-world barriers between visits, plus how NCODA’s standards-driven pharmacy support helped keep care on track.
January 21, 2026
S9 E15: Theranostics: The New Era of Targeted Imaging & Therapy
Nick Mastiscusa, PharmD, discusses the evolving role of nuclear pharmacy and theranostics in cancer care, including targeted radiopharmaceutical therapies and patient safety considerations. This episode offers 1.0 CE hour for pharmacists and pharmacy technicians.
December 17, 2025
S9 E14: Immunotherapy and the MyMelanoma Project
Oxford’s Mark Middleton discusses how immunotherapy transformed melanoma outcomes, what researchers have learned along the way, and why projects like MyMelanoma are redefining real-world evidence.
December 10, 2025